Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?

Abstract Background Infectious diseases (IDs) are highly relevant after solid organ transplantation in terms of morbidity and mortality, being among the most common causes of death. Patients undergoing kidney retransplantation (re-K-Tx) have been already receiving immunosuppressive therapy over a prolonged period, potentially facilitating subsequent infections. Comparing ID events after re-K-Tx and first kidney transplantation (f-K-Tx) can delineate patterns and risks of ID events associated with prolonged immunosuppression. Methods We included adult patients with records on f-K-Tx and re-K-Tx in the Swiss Transplant Cohort Study. We analyzed ID events after f-K-Tx and re-K-Tx within the same patients and compared infection rates, causative pathogens, and infection sites. Recurrent time-to-event analyses were performed for comparison of infection rates. Results A total of 59 patients with a median age of 47 years (range, 18–73) were included. Overall, 312 ID events in 52 patients occurred. In multivariable recurrent event modeling, the rate of ID events was significantly lower after re-K-Tx (hazard ratio, 0.70; P = .02). More bacterial (68.9% vs 60.4%) and fungal (4.0% vs 1.1%) infections were observed after f-K-Tx but fewer viral infections (27.0% vs 38.5%) as compared with re-K-Tx (P = .11). After f-K-Tx, urinary and gastrointestinal tract infections were more frequent; after re-K-Tx, respiratory tract and surgical site infections were more frequent (P < .001). Conclusions ID events were less frequent after re-K-Tx. Affected sites differed significantly after f-K-Tx vs re-K-Tx.

[1]  T. Sengstag,et al.  Surgical site infections after kidney transplantation are independently associated with graft loss. , 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  T. Mühlbacher,et al.  Standardized, risk-adapted induction therapy in kidney transplantation , 2023, Journal of Nephrology.

[3]  O. de Rougemont,et al.  Kidney Retransplantation after Graft Failure: Variables Influencing Long-Term Survival , 2022, Journal of transplantation.

[4]  C. Couchoud,et al.  Association between kidney retransplantation and survival according to age in the French national cohort of dialysis patients , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  O. Manuel,et al.  Impact of different urinary tract infection phenotypes within the first year post‐transplant on renal allograft outcomes , 2022, American Journal of Transplantation.

[6]  J. Lundgren,et al.  Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death , 2022, medRxiv.

[7]  D. Seehofer,et al.  Recipient obesity as a risk factor in kidney transplantation , 2022, BMC Nephrology.

[8]  M. Ison,et al.  Outcomes of repeat kidney transplantation following prior graft failure secondary to BK nephropathy: A single‐center retrospective study , 2021, Transplant infectious disease : an official journal of the Transplantation Society.

[9]  S. Linnenweber-Held,et al.  Risk Factors Influencing the Outcomes of Kidney Re-Transplantation , 2021, Annals of transplantation.

[10]  N. Mueller,et al.  Differences Between Infectious Disease Events in First Liver Transplant Versus Retransplantation in the Swiss Transplant Cohort Study , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  T. Rimmele,et al.  Renal transplantation outcomes in obese patients: a French cohort-based study , 2021, BMC Nephrology.

[12]  F. Ruschitzka,et al.  Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Chadban,et al.  Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  C. Thongprayoon,et al.  Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  L. Riella Understanding the causes of mortality post-transplantation - there is more than meets the eye , 2018, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[16]  G. Danovitch,et al.  Kidney retransplantation for BK virus nephropathy with active viremia without allograft nephrectomy , 2015, Journal of Nephrology.

[17]  C. Lovis,et al.  Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort , 2013, European Journal of Epidemiology.

[18]  D. Dadhania,et al.  Results of Repeat Renal Transplantation After Graft Loss From BK Virus Nephropathy , 2011, Transplantation.

[19]  J. Cooper,et al.  Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomy. , 2010, Transplantation.

[20]  K. Abbott,et al.  Retransplantation After BK Virus Nephropathy in Prior Kidney Transplant: An OPTN Database Analysis , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  B. Knebelmann,et al.  Cyst infections in patients with autosomal dominant polycystic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[22]  J. Fishman,et al.  Infectious complications of antilymphocyte therapies in solid organ transplantation. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Perfect,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Tollemar,et al.  Urinary tract infections following renal transplantation. , 1998, Transplantation proceedings.

[25]  T. Starzl,et al.  Causes of death after kidney transplantation. , 1983, JAMA.

[26]  E. Alexopoulos,et al.  Urinary tract infections after renal transplantation. , 1985, Drugs under experimental and clinical research.